AzTrials
AzTrials

Zygomatic Arch FractureNCT04528264

Ultrasound Guided Closed Reduction of Depressed Zygomatic Arch Fractures

A study testing Intraoperative ultrasound guided and Conventional blind reduction technique in people with Zygomatic Arch Fracture, run by College of Medical Sciences Teaching Hospital. Nepal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Zygomatic arch fractures have always been treated with blind closed reduction and is the most commonly used method. Blind reduction of fractures might lead to inadequate reduction and associated complications of facial asymmetry and limitations in mouth opening which may require reoperation for correction. Read more about this study

Who is it for?
Ages 6 years and olderHealthy volunteers can take part
Conditions the study is for
Zygomatic Arch Fracture
What is being tested?
Intraoperative ultrasound guided and Conventional blind reduction technique
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
Jun 2021to Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • 6 years and above
  • fractured and depressed zygomatic arch requiring surgical reduction

Who cannot join

  • pregnant patients
  • not willing for participation
  • below 6 years age

Trial locations and contacts

No sites are listed yet.

Ashutosh K Singh, MDS contact

+9779804244369

dr.ashutosh@cmsnepal.edu.np

About this study

Official title: Ultrasound Guided Closed Reduction of Depressed Zygomatic Arch Fractures Compared to Conventional Blind Reduction: A Randomized Double Blind Clinical Trial

Zygomatic arch fractures have always been treated with blind closed reduction and is the most commonly used method. Blind reduction of fractures might lead to inadequate reduction and associated complications of facial asymmetry and limitations in mouth opening which may require reoperation for correction. Various methods like portable CT scan, C arm fluoroscopy, endoscopy and ultrasound have been proposed and used to visualize the reduction for better outcome. Out of these, ultrasound is inexpensive, easily available, easy to use, non-ionizing and has greatest potential to be used as standard for visual reduction of zygomatic arch fractures. There are studies where ultrasound has been compared to blind method and other modalities but level I evidence and recommended protocol for its intraoperative use has been lacking.

Read the detailed description

Isolated and depressed zygomatic arch fractures have an incidence of about 5 to 14% of lateral mid face fractures. Depressed zygomatic arch fractures have been managed by blind closed reduction historically based upon tactile sense of surgeon and auditory click assumed as the conclusive evidence of reduction. The minimal fracture exposure for zygomatic arch fractures either solitary or combined with zygomaticomaxillary complex fractures results in inadequate visibility of the fractures and inadequate or inappropriate reduction of fractures. These fractures can be visualized by surgical exposure with coronal approach but is limited by complications and extensive training required. Other options are intraoperative imaging with portable CT scan but they are cumbersome, require radiologists for positioning and are not available in all operative units as well as expensive. Endoscopic visualization and reduction are another option for intraoperative control of these fractures but endoscopes are expensive, not available in all operative units and require experience and training to use appropriately. Various studies and our own experience show that unacceptable number of depressed zygomatic arch fractures remain incompletely reduced with blind reduction method. The resulting deficit might be as small as a depressed lateral face, inadequate sagittal projection of cheek to inadequate mouth opening. Portable ultrasound machines are readily available in almost all anesthesia units and operating rooms. These ultrasound units can be utilized to reduce the zygomatic arch satisfactorily with real time image guidance and it has advantage of being radiation free and inexpensive compared to fluoroscopy based portable C arm units. A small pilot in our own unit has shown remarkable difference between reduction achieved under ultrasonography guidance vs closed reduction based on tactility. This method should be explored and perfected to bring in common use among Oral \& Maxillofacial surgeons so that blind assumption of fracture reduction is replaced by a more scientific confirmation of fracture reduction.

Being tested
Intraoperative ultrasound guided, Conventional blind reduction technique
Keywords
zygomatic arch fracture, Intraoperative Imaging, guided reduction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intraoperative ultrasound guidedDevice

    Also called Intraoperative USG Imaging

    Samsung Mysono U6 machine with LN 15 linear (https://www.samsunghealthcare.com/en/products/UltrasoundSystem/MySono%20U6/General%20Imaging/transducers) probe capable of Musculoskeletal imaging will be used for visualization and location of fracture after which elevation and reduction of fracture will be attempted. The ultrasound probe will be used as described by McCann. Radiographic continuity of periosteal shadow without any step will be taken as end point for reduction and the procedure will be terminated.

  • Conventional blind reduction techniqueOther

    Also called comparator

    Conventional blind reduction technique

Study groups in NCT04528264
Study groupRoleWhat they receive
Ultrasound guidedExperimentalIntraoperative high frequency ultrasound used to guide the reduction of depressed zygomatic arch.
Receives: Device: Intraoperative ultrasound guided
Conventional blind reduction techniqueOtherConventional blind reduction of zygomatic arch fracture will be conducted without any intraoperative imaging.
Receives: Other: Conventional blind reduction technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post operative radiographic evidence of adequate reduction

    The radiographic evaluation will be performed blinded by one of the clinician oral and maxillofacial surgeons who will not be involved in any of the operations. The adequacy of reduction will be evaluated in a DICOM viewing software on axial scans to assess contour of the arch and step if any at the fracture site.

    1. Good reduction : Absence of any step and straight contour of zygomatic arch symmetric to contralateral uninjured arch
    2. Average reduction: Absence of any step but poor contour of zygomatic arch and asymmetric to contralateral uninjured arch
    3. Poor reduction: Presence of both a cortical step and asymmetric arch compared to contralateral uninjured arch

    Measured: 24 hours

  2. Facial profile symmetry

    Clinical assessment will be performed blinded by a clinician oral and maxillofacial surgeon who will not be involved in any of the operations on first postoperative day, first follow up visit after one week of operation and 4 weeks of operation. Facial symmetry and projection will be assessed clinically by the clinician and graded as good, adequate and poor. A patient oriented clinical outcome is considered good practice and clinically relevant in modern evidence based medicine so patient response will be recorded as binary (yes/no) response regarding their view on facial symmetry.

    Measured: one week to four weeks

  3. Number of reoperations

    Revision surgery required after failed reduction assessed and confirmed radiographically on CT scan and clinical assessment as well as patient reported measure of facial symmetry and adequate mouth opening.

    Measured: 24 hours

  4. Mouth opening

    Interincisal opening measured between the incisal tips of central incisor teeth and recorded in millimeter using a vernier caliper.

    Measured: at 24 hours postoperatively

Secondary outcomes (3)
  1. Operative time

    Additional time required to reduce with intervention.

    Measured: Intraoperative

  2. Number of attempts or reduction

    Additional attempts required with imaging guidance.

    Measured: Intraoperative

  3. Cost of intervention

    Additional cost required with imaging guidance.

    Measured: Intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2020
  2. Study startJun 2021 (estimated)
  3. Primary completionOct 2021 (estimated)
  4. Study completionAug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized double blind
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04528264
Sponsor's protocol ID
CMSNepal
Status last verified
Oct 2020
First submitted
22 Aug 2020
Last updated
14 Oct 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Fully sharable link will be provided after study completion with deidentified data

Questions about this trial

What is this clinical trial studying?

A study testing Intraoperative ultrasound guided and Conventional blind reduction technique in people with Zygomatic Arch Fracture, run by College of Medical Sciences Teaching Hospital. Nepal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ashutosh K Singh, MDS (+9779804244369, dr.ashutosh@cmsnepal.edu.np), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post operative radiographic evidence of adequate reduction (time frame: 24 hours). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in